Lecanemab Linked to Death in AD Patient With Stroke Given tP

A case report links the investigational Alzheimer's drug to numerous severe intracerebral hemorrhages during thrombolysis treatment.

Related Keywords

Chicago , Illinois , United States , Arizona , California , Phoenix , New Haven , Connecticut , Yale University , San Francisco , Sherry Hsiang Yi Chou , Marwan Sabbagh , Michael Weiner , University Of California , Barrow Neurological Institute , Yale University School Of Medicine , Drug Administration , Northwestern University Feinberg School Of Medicine , New England Journal , Prescription Drug User Fee Act , Northwestern University Feinberg School , Early Alzheimer , Yale University School , Medscape Cardiology , Alzheimers Disease , Lzheimer Disease , Stroke Risk , Hemorrhagic Stroke , Patient Safety , Experimental Drug , Monoclonal Antibody , Etuximab , Ituximab , Antidementia Agents , Adverse Effects , Side Effects , Amyloid Plaque , Tissue Plasminogen Activator Tpa , Pa Tissue Plasminogen Activator , Intracerebral Hemmorhage , Brain , Vasculitis , Anticoagulation Therapy , Anticoagulant , Anticoagulation , Dementia , Elder ,